NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 50 filers reported holding NUVALENT INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,786,839 | +8.3% | 60,623 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $2,573,297 | +174124.6% | 61,022 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $1,477 | -17.9% | 56,620 | -6.3% | 0.00% | 0.0% |
| Q4 2022 | $1,800 | -99.8% | 60,447 | +61.4% | 0.00% | – |
| Q3 2022 | $728,000 | +29.3% | 37,452 | -9.7% | 0.00% | – |
| Q2 2022 | $563,000 | +76.5% | 41,491 | +56.4% | 0.00% | – |
| Q1 2022 | $319,000 | +2.6% | 26,526 | +68.4% | 0.00% | – |
| Q4 2021 | $311,000 | -12.4% | 15,749 | 0.0% | 0.00% | – |
| Q3 2021 | $355,000 | – | 15,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,788,981 | $83,055,854 | 13.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $595,332,695 | 12.32% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $106,531 | 11.90% |
| COMMODORE CAPITAL LP | 913,621 | $27,208 | 4.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 302,963 | $9,022,238 | 2.58% |
| Boxer Capital, LLC | 1,210,192 | $36,039,518 | 1.90% |
| Perceptive Advisors | 2,255,007 | $67,154,108 | 1.89% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,673,214 | $49,828,313 | 0.74% |
| Avoro Capital Advisors LLC | 1,555,555 | $46,324,428 | 0.69% |
| AlphaCentric Advisors LLC | 15,500 | $461,590 | 0.46% |